Inhibits the enzymatic activity of phospholipase A2 (PA2). Occurs as a mixture of oligomers. Tetrameric arrangement appears to be the predominant quaternary structure. Secreted in blood plasma. Expressed by the liver. Belongs to the CNF-like-inhibitor family.